Heterozygous inactivating mutations of glucokinase cause type 2 maturity onset diabetes of the young (MODY2), and homozygous or compound heterozygous inactivating glucokinase mutations cause a more severe phenotype known as permanent neonatal diabetes mellitus (PNDM), which manifests at birth9. This evidence concerns the gene GCK and MODY.